Overview

Phase I Combination Ixabepilone + Cisplatin

Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the highest dose of ixabepilone that can be given safely with cisplatin without causing severe or life-threatening side effects and for some patients with non-small cell lung cancer, the effects (good or bad) on your cancer will also be studied
Phase:
Phase 1
Details
Lead Sponsor:
R-Pharm
Treatments:
Cisplatin
Epothilones